National safety data of post-marketing use of omalizumab in severe persistent asthma in Turkey

Dursun, ABavbek, SMisirligil, ZErdener, FBuyukozturk, SAydin, OGemicioglu, BBayrak, PErkekol, FOYildirim, ZCilli, ABoz, ABAlpaydyn, AOKarakoc, GGorguner, MKarakaya, GIsik, RSapan, NBakirtas, A2025-04-102025-04-100105-4538http://hdl.handle.net/20.500.14701/42944EnglishNational safety data of post-marketing use of omalizumab in severe persistent asthma in TurkeyMeeting Abstract1398-9995